
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 06, 2021, titled "Stelis Biopharma appoints Mark W. Womack as the new CEO".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 06, 2021, titled "Stelis Biopharma appoints Mark W. Womack as the new CEO".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science